CYP7A1 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP7A1 monoclonal antibodies for research focused on understanding this critical enzyme. CYP7A1 Antibodies are validated for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP7A1, or cytochrome P450 7A1, is a key enzyme in the cholesterol catabolism pathway, responsible for the conversion of cholesterol to bile acids. This process is vital for maintaining cholesterol homeostasis and plays a significant role in lipid metabolism. Dysregulation of CYP7A1 has been implicated in various metabolic disorders, making it an important target for research in cardiovascular and liver diseases. Understanding CYP7A1's role in cholesterol metabolism can provide valuable insights into potential therapeutic strategies. Research into CYP7A1 continues to reveal new aspects of its regulatory mechanisms and physiological importance. Investigating CYP7A1 function helps illuminate the complex relationship between cholesterol metabolism and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CYP7A1's role in human health and disease.